Filtered By:
Infectious Disease: Hepatitis
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 2175 results found since Jan 2013.
Liver abscess as a atypical presentation of hepatocellular carcinoma
We present the case of a 64-year-old male with a history of chronic liver disease due to hepatitis C virus, with a sustained viral response after oral antiviral treatment and without follow-up for 5 years. He was admitted after a one-month history of constitutional symptoms, low-grade fever, abdominal pain and a palpable epigastric tumor. Analysis showed marked elevation of acute phase reactants (48,000 leukocytes and C-reactive protein of 19mg/dl) and dissociated cholestasis. Two lesions were identified by abdominal CT.PMID:36353952 | DOI:10.17235/reed.2022.9235/2022
Source: Revista Espanola de Enfermedades Digestivas - November 10, 2022 Category: Gastroenterology Authors: Ana Su árez-Saro Fernández Flor Mar ía Fernández-Gordón Sánchez Carolina Mu ñoz Codoceo Álvaro Hidalgo Romero Inmaculada Fern ández Vázquez Source Type: research
Characteristics and outcomes of acute hepatitis of unknown etiology in Egypt: first report of adult adenovirus-associated hepatitis
CONCLUSION: This is the first report describing etiologies and characteristics of AHUE cases in Egypt, and interestingly, adenovirus was detected in adults. Further studies are required to determine the prevalence of this newly emerging viral hepatitis pathogens.PMID:36334256 | DOI:10.1007/s15010-022-01945-1
Source: Herpes - November 5, 2022 Category: Infectious Diseases Authors: Haidi Karam-Allah Ramadan Ibrahim M Sayed Amal A Elkhawaga El-Zahraa M Meghezel Ashraf A Askar Abdelmajeed M Moussa Asmaa O B S Osman Azza Abo Elfadl Walaa A Khalifa Ahmed M Ashmawy Mohamed A El-Mokhtar Source Type: research
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand
In conclusion, most of the patients with chikungunya did not have significant liver involvement. In those patients with severe liver injury, coexisting causes should be considered.PMID:36252802 | DOI:10.4269/ajtmh.22-0339
Source: Am J Trop Med Hyg - October 17, 2022 Category: Infectious Diseases Authors: Punyavee Srikirin Tanaya Siripoon Lantharita Charoenpong Ngamphol Soonthornworasiri Wasin Matsee Chatporn Kittitrakul Pisit Tangkijvanich Prakaykaew Charunwatthana Kittiyod Poovorawan Source Type: research
